Related Experiment Video
Updated: Apr 19, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Evidence for Direct Inhibition of MHC-Restricted Antigen Processing by Dexamethasone
Sun-A Im1, Turmunkh Gerelchuluun2, Chong-Kil Lee1
1College of Pharmacy, Chungbuk National University, Cheongju 362-763, Korea.
Abstract:
Dexamethasone (Dex) was shown to inhibit the differentiation, maturation, and antigen-presenting function of dendritic cells (DC) when added during DC generation or maturation stages. Here, we examined the direct effects of Dex on MHC-restricted antigen processing. Macrophages were incubated with microencapsulated ovalbumin (OVA) in the presence of different concentrations of Dex for 2 h, and the efficacy of OVA peptide presentation was evaluated using OVA-specific CD8 and CD4 T cells. Dex inhibited both class I- and class II-restricted presentation of OVA to T cells; this inhibitory effect on antigen presentation was much more potent in immature macrophages than in mature macrophages. The presentation of the exogenously added OVA peptide SIINFEKL was not blocked by Dex. In addition, short-term treatment of macrophages with Dex had no discernible effects on the phagocytic activity, total expression levels of MHC molecules or co-stimulatory molecules. These results demonstrate that Dex inhibits intracellular processing events of phagocytosed antigens in macrophages.
Insights
Dexamethasone (Dex) inhibits antigen processing in macrophages, impacting T cell responses. This steroid treatment blocks the presentation of phagocytosed antigens, particularly in immature cells.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Dexamethasone (Dex) is known to affect dendritic cell (DC) functions.
- Understanding Dex's impact on antigen processing in other immune cells is crucial.
Purpose of the Study:
- To investigate the direct effects of Dexamethasone on MHC-restricted antigen processing in macrophages.
- To determine if Dex interferes with the intracellular processing of phagocytosed antigens.
Main Methods:
- Macrophages were incubated with microencapsulated ovalbumin (OVA) and varying concentrations of Dex.
- OVA-specific CD8 and CD4 T cell responses were used to assess antigen presentation efficacy.
- Presentation of exogenously added OVA peptide SIINFEKL was also evaluated.
Main Results:
- Dex inhibited both MHC class I and class II restricted presentation of OVA to T cells.
- The inhibitory effect was more pronounced in immature macrophages compared to mature ones.
- Dex did not block the presentation of exogenous SIINFEKL peptide and did not affect phagocytosis or MHC/co-stimulatory molecule expression.
Conclusions:
- Dexamethasone directly inhibits intracellular processing of phagocytosed antigens in macrophages.
- This inhibition affects antigen presentation to both CD4+ and CD8+ T cells.
- The findings highlight Dex's role in modulating macrophage antigen processing pathways.
More Related Videos
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
Related Concept Videos
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...